Abstract
The authors report on their experience with combined etomidate anaesthesia in 500 varied surgical procedures including thoracic and neurosurgery. Specific indications for the new short-term hypnotic etomidate are dealt with, including anaesthesia in poor-risk patients, conditions of shock, spastic bronchitis, and bronchial asthma.
When used for the induction of neuroleptic analgesia, etomidate offers certain benefits. Since it induces few side-effects, it is suggested that this preparation is the drug of choice for ambulatory anaesthesia, Caesarean section, etc.
Get full access to this article
View all access options for this article.
